173 related articles for article (PubMed ID: 6073582)
1. [Asymptomatic diabetes mellitus in normal weight subjects with hypertension. Studies on glucose tolerance, serum insulin and nonesterified fatty acids in essential hypertension].
Dieterle P; Fehm H; Ströder W; Henner J; Bottermann P; Schwarz K
Dtsch Med Wochenschr; 1967 Dec; 92(52):2376-81. PubMed ID: 6073582
[No Abstract] [Full Text] [Related]
2. Asymptomatic diabetes mellitus in hypertensive patients of normal weight. Glucose tolerance and serum levels of insulin and nonesterified fatty acids in essential hypertension.
Dieterle P; Fehm H; Ströder W; Henner J; Bottermann P; Schwarz K
Ger Med Mon; 1968 Oct; 13(10):478-83. PubMed ID: 5707015
[No Abstract] [Full Text] [Related]
3. [Obesity and diabetes. II. Tolbutamide intravenous test in obese patients].
Torri A; Zandomeneghi R; Sgarbi E
Endocrinol Sci Cost; 1970 May; 31(2):88-99. PubMed ID: 5470191
[No Abstract] [Full Text] [Related]
4. [Genetics of diabetes mellitus: glucose tolerance, serum insulin and free fatty acids in monozygotic twins].
Daweke H; Grote W; Gries FA; Liebermeister H
Dtsch Med Wochenschr; 1970 May; 95(18):983-8. PubMed ID: 5424947
[No Abstract] [Full Text] [Related]
5. Studies in subjects with positive postprandial Clinistix test. 3. Special studies and follow-up of cases with borderline glucose tolerance.
Carlström S; Lundquist A; Lundquist I; Nordén A; Scherstén B; Wollmark G
Acta Med Scand; 1971 May; 189(5):415-22. PubMed ID: 5578492
[No Abstract] [Full Text] [Related]
6. [Intravenous tolbutamide test in the diagnosis of diabetes. Critical review and case studies].
Fuà C; Mazzi F; Peracino
Clin Ter; 1972 Feb; 60(3):229-43. PubMed ID: 4579709
[No Abstract] [Full Text] [Related]
7. [Lipacidemia and glycemia variations during intravenous tolbutamide test of 126 normal and diabetic persons].
Deuil R; Deloux G; Duval JM; Davy J; Guinard UJ; Letailleur M
Diabete; 1968; 16(1):45-53. PubMed ID: 5743942
[No Abstract] [Full Text] [Related]
8. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
Ulrich E; Frank I; Kujat G; Müller G; Seige K
Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
[No Abstract] [Full Text] [Related]
9. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
10. Response of plasma insulin, serum free fatty acids and blood glucose in growth onset diabetics, to I.V. tolbutamide.
Kirti S; Dutta PK; Vaishnava H; Singh RB
J Assoc Physicians India; 1976 Mar; 24(3):141-6. PubMed ID: 1010812
[No Abstract] [Full Text] [Related]
11. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
Bigelow-Sherman JD; Shima K; Borden EK; Foà PP; Penhallegon R
Acta Diabetol Lat; 1970; 7(1):68-92. PubMed ID: 5493440
[No Abstract] [Full Text] [Related]
12. Thyroidectomy and cortisol therapy. Their effects on blood sugar, serum immunoreactive insulin and free fatty acids during an oral glucose tolerance test.
Renauld A; Sverdlik RC; Foglia VG
Acta Physiol Lat Am; 1974; 24(2):143-52. PubMed ID: 4451125
[No Abstract] [Full Text] [Related]
13. [Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].
Perreau P; Joubaud F; Cheguillaume J; Boyer J; Vernin H
Sem Hop; 1972 Mar; 48(14):957-66. PubMed ID: 4339074
[No Abstract] [Full Text] [Related]
14. [Early diagnosis of diabetic disease].
Sensi S
Minerva Med; 1973 Sep; 64(62):3219-49. PubMed ID: 4775165
[No Abstract] [Full Text] [Related]
15. [Metabolical aspects after prolonged fasting in obese subjects].
Cravetto CA; Favero A; Cravario A
Folia Endocrinol; 1973 Apr; 26(2):139-52. PubMed ID: 4740872
[No Abstract] [Full Text] [Related]
16. Insulin responsiveness in obese diabetic patients.
Alfici C; Cottini EP; Domínguez JM
Medicina (B Aires); 1972; 32(5):486-92. PubMed ID: 4649560
[No Abstract] [Full Text] [Related]
17. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
Göschke H; Denes A; Girard J; Collard F; Berger W
Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
[No Abstract] [Full Text] [Related]
18. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
Stefan N; Stumvoll M; Bogardus C; Tataranni PA
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
[TBL] [Abstract][Full Text] [Related]
19. Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes.
Ferrari C; Testori GP; Bertazzoni A; Romussi M; Caldara R; Frezzati S
Horm Metab Res; 1978 Jan; 10(1):4-6. PubMed ID: 631736
[TBL] [Abstract][Full Text] [Related]
20. Liver disease, insulin antagonism and diabetes mellitus.
Creutzfeldt W; Frerichs H; Kneer P
Horm Metab Res; 1974; Suppl 4():135-42. PubMed ID: 4423508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
